Clearside Biomedical, Inc. Soared
Wed, Jun 23, 2021 at 05:30 PM
Clearside Biomedical, Inc. (CLSD:NASDAQ) soared at $5.38, representing a gain of 18.5%. The stock got featured on our News Catalysts scanner on Tue, Jun 15, 2021 at 05:03 PM in the 'MISCELLANEOUS' category. From Tue, Jun 08, 2021, the stock recorded 60.00% Up Days and 45.45% Green Days
The stock spiked on Thu, Jun 17, 2021 at $6 with a volume of 43M+.
About Clearside Biomedical, Inc. (CLSD:NASDAQ)
Clearside Biomedical Inc is a clinical biopharmaceutical company. It is engaged in developing drug therapies to treat blinding diseases of the eye.
Top 10 Gainers:
- MCAE (MCAE:NASDAQ), 100%
- Entera Bio Ltd. (ENTX:NASDAQ), 44.77%
- Bellerophon Therapeutics, Inc. (BLPH:NASDAQ), 30.39%
- ORPH (ORPH:NASDAQ), 24.62%
- Moxian, Inc. (MOXC:NASDAQ), 21.98%
- Loop Industries, Inc. (LOOP:NASDAQ), 20.55%
- KRBP (KRBP:NASDAQ), 20.54%
- AUUD (AUUD:NASDAQ), 18.54%
- Clearside Biomedical, Inc. (CLSD:NASDAQ), 18.5%
- SeaChange International, Inc. (SEAC:NASDAQ), 18.1%